Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men

This publication has 46 references indexed in Scilit:

• Impaired fibrinolysis and risk of thromboembolism
  Progress in Cardiovascular Diseases, 1991
• Introduction
  The American Journal of Cardiology, 1991
• Plasma triglyceride and coronary heart disease.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Dietary regulation of fibrinolytic factors
  Atherosclerosis, 1990
• Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a North Swedish population
  Atherosclerosis, 1989
• Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
• Impaired fibrinolysis in coronary artery disease
  American Heart Journal, 1988
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia Clinical and laboratory studies in two afflicted families
  European Journal of Clinical Investigation, 1982